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Abstract: Vitamin D and calcium supplementation have been posited to improve body composition
and different formulations of calcium may impact bioavailability. However, data are lacking
regarding the combinatorial effects of exercise, diet, and calcium and/or vitamin D supplementation
on body composition changes in post-menopausal women. Herein, 128 post-menopausal women
(51.3 ± 4.5 years, 36.4 ± 5.7 kg/m2 , 46.2 ± 4.5% fat) were assigned to diet and supplement groups while
participating in a supervised circuit-style resistance-training program (3 d/week) over a 14-week
period. Diet groups included: (1) normal diet (CTL), (2) a low-calorie, higher protein diet (LCHP; 1600
kcal/day, 15% carbohydrates, 55% protein, 30% fat), and (3) a low-calorie, higher carbohydrate diet
(LCHC; 1600 kcal/day, 55% carbohydrates, 15% protein, 30% fat). Supplement groups consisted of:
(1) maltodextrin (PLA), (2) 800 mg/day of calcium carbonate (Ca), and (3) 800 mg/day of calcium citrate
and malate and 400 IU/day of vitamin D (Ca+D). Fasting blood samples, body composition, resting
energy expenditure, aerobic capacity, muscular strength and endurance measures were assessed. Data
were analyzed by mixed factorial ANOVA with repeated measures and presented as mean change
from baseline [95% CI]. Exercise training promoted significant improvements in strength, peak aerobic
capacity, and blood lipids. Dieting resulted in greater losses of body mass (CTL −0.4 ± 2.4; LCHC
−5.1 ± 4.2; LCHP −3.8 ± 4.2 kg) and fat mass (CTL −1.4 ± 1.8; LCHC −3.7 ± 3.7; LCHP −3.4 ± 3.4 kg).
When compared to LCHC-PLA, the LCHC + Ca combination led to greater losses in body mass
(PLA −4.1 [−6.1, −2.1], Ca −6.4 [−8.1, −4.7], Ca+D −4.4 [−6.4, −2.5] kg). In comparison to LCHC-Ca,
the LCHC-Ca+D led to an improved maintenance of fat-free mass (PLA −0.3 [−1.4, 0.7], Ca −1.4
[−2.3, −0.5], Ca+D 0.4 [−0.6, 1.5] kg) and a greater loss of body fat (PLA −2.3 [−3.4, −1.1], Ca −1.3
[−2.3, −0.3], Ca+D −3.6 [−4.8, −2.5]%). Alternatively, no significant differences in weight loss or body
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composition resulted when adding Ca or Ca+D to the LCHP regimen in comparison to when PLA
was added to the LCHP diet. When combined with an energy-restricted, higher carbohydrate diet,
adding 800 mg of Ca carbonate stimulated greater body mass loss compared to when a PLA was
added. Alternatively, adding Ca+D to the LCHC diet promoted greater% fat changes and attenuation
of fat-free mass loss. Our results expand upon current literature regarding the impact of calcium
supplementation with dieting and regular exercise. This data highlights that different forms of
calcium in combination with an energy restricted, higher carbohydrate diet may trigger changes in
body mass or body composition while no impact of calcium supplementation was observed when
participants followed an energy restricted, higher protein diet.
Keywords: weight loss; dietary supplement; fat loss; training adaptations

1. Introduction
The overweight and obesity pandemic poses a global burden, with as many as 1.5 billion people,
or roughly 20% of the world population being affected [1] while a 2019 report stating that by the year
2030 50% of U.S. adults will have obesity [2]. In addition, many reports have highlighted the fact that
this dilemma poses severe economic consequences [3,4]. In this regard, obese persons bear medical
and prescription medicine costs that are approximately 30% greater than normal-weight peers [5]
or approximately $2700 USD annually [6]. Furthermore, lost quantity of lifetime in obese persons
has been estimated to be as high as 20 years compared to normal-weight peers [7]. Hence, while the
World Health Organization reports that life expectancy in developed countries is nearly 80 years old,
debilitation resulting from obesity can begin (and rapidly accelerate) as early as the fifth decade of
life. Although the causes of obesity stem from environmental and genetic factors, post-menopausal
women may be at increased risk due to factors such as reductions in circulating sex hormones [8,9],
decrements in whole-body metabolism due to the lack or irregular presence of a menstrual cycle [10]
and gender-independent aging mechanisms [11]. Therefore, countermeasures to reduce obesity rates
continue to be the focus of much scientific research, particularly in post-menopausal women given
their relative susceptibility for developing the disease.
It is well established that exercise [12–15] and/or engaging in hypocaloric higher-protein/
lower-carbohydrate diets [14,16,17] improves body composition in overweight and obese individuals.
These reports extend to post-menopausal women, whereby researchers have reported that exercise
training [18] and higher protein, lower-carbohydrate dieting can improve body composition [19].
Beyond diet and exercise interventions, supplementing the diet with select micronutrients may be a
viable non-pharmaceutical option in augmenting weight loss. For instance, high calcium intakes have
been associated with higher levels of fat oxidation [20] and increased satiety [21], while vitamin D
signaling has also been reported to favorably affect the expression patterns of lipolytic and thermogenic
genes in adipose tissue [22,23]. In multiple reports, Zemel and colleagues [24–26] first highlighted
the potential impact of calcium and dairy on weight loss, weight gain, and fat loss. In this respect,
initial animal work demonstrated attenuations of adipocyte accretion [27] and weight gain while
manipulating calcitriol levels has been shown to impact weight gain [26]. Further, diets higher in
calcium in transgenic animal work has been shown to impede fat loss [24]. These authors purported
that a mechanistic impact of calcium may be linked to various bioactive compounds found in dairy
that act synergistically with calcium. Additionally, evidence by Wang et al. [28] suggested that different
forms of calcium (citrate vs. malate) have differing levels of bioavailability in healthy, premenopausal
women. In a crossover design, identical doses (1000 mg) of calcium carbonate (1000 mg powder) and
calcium citrate (2 × 500 mg tablets) were provided and pharmacokinetic patterns of blood calcium
levels were compared. Results indicated that a single serving of calcium carbonate powder was
more bioavailable than calcium citrate tablets. Interestingly, a previous clinical trial [29] reported that
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both higher dairy calcium intake and relatively high serum vitamin D were associated with a greater
diet-induced weight loss over a two-year intervention, and other evidence also suggests that calcium
and vitamin D supplementation can facilitate weight loss [21]. However, others have reported that
calcium supplementation does not affect body composition in subjects participating in longer-term
weight loss interventions [30,31]. Likewise, a recent meta-analysis suggests that there is equivocal
evidence with regards to calcium facilitating weight loss, and there is a lack of evidence with regards
to vitamin D supplementation being able to improve body composition [32]. Notwithstanding, the
aforementioned investigations differed with regards to dietary strategies for weight loss, and most of
the studies did not have participants engaging in concomitant exercise training.
While there have been a plethora of data examining the effects of vitamin D and calcium
supplementation on weight loss, the potential combinatorial effects of exercise with certain diet
prescriptions in combination with calcium and/or vitamin D supplementation on body composition
changes requires additional investigation. Moreover, the combinatorial effects of exercise, dieting, and
nutritional supplementation on body composition changes has been less studied in post-menopausal
overweight women in general. This study assesses whether supplementing the diet with different types
of calcium (with or without vitamin D) affects changes in body composition in women participating
in a 14-week popular exercise and weight loss program (no diet versus hypocaloric lower- and
higher-carbohydrate diets) in previously sedentary post-menopausal subjects. Notably, the exercise
program used in this proposed study consists of a 30-min circuit-style exercise program that targets all
major muscle groups using bi-directional resistance training machines. Millions of women using the
Curves International exercise program use this program worldwide and it has been used successfully
in other research studies to stimulate weight and improve health, aerobic fitness, and musculoskeletal
fitness. This In light of previously highlighted data, different forms of calcium were investigated in
the current study to identify their potential impact on body mass loss and body composition changes.
Further, alterations in macronutrient amounts were utilized to identify any combinatory impact of
these different forms of calcium in combination with vitamin D due to the observed potential for
diets containing different amounts of macronutrients to impact body composition changes [14,33–35].
Thus, we hypothesized that individuals on the lower-carbohydrate diet would experience a greater
improvement in body composition compared to those that did not diet and/or those that were assigned
to the higher-carbohydrate diet. Moreover, we hypothesized that, irrespective of diet composition,
participants supplementing with calcium and vitamin D would experience better improvements in
body composition. Secondary objectives of this study were to also examine if the implemented diet
and supplementation strategies with exercise affected resting metabolism and fitness status.
2. Methods
2.1. Experimental Design
This study was conducted in a randomized, parallel arm, prospective manner at a university-based
research facility. The randomization was completed in a block format with two times (2:1:1) the people
being assigned to LCHP and LCHC to account for anticipated greater attrition in these groups. This
research protocol was reviewed and approved by the Baylor University Institutional Review Board
(IRB 2008-0480) prior to initiation of the study in accordance with the Declaration of Helsinki [36] and
subsequently approved by the Texas A&M Human Participant Protection Board (IRB 2008-0643F) when
the principal investigator moved to that institution. The overall study design including the dietary
assignment and exercise program were modeled after the Curves for Women exercise program that has
been and is still being used by millions of women worldwide. The specific focus of this investigation
was to identify the impact of adding different forms of calcium supplementation with and without
the addition of vitamin D to energy restricted diets of higher and lower proportions of carbohydrate
and protein. The primary outcomes for this investigation were weight loss and body composition
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machine. Between machines, participants performed floor-based exercises (e.g., stepping, calisthenics,
etc.) for 30-s with a goal of maintaining an elevated heart rate. Thus, each participant completed 30-s
on a machine, followed by 30-s of floor-based calisthenics until they completed two complete circuits
(26 stations total). A brief period of stretching was completed following the completion of their exercise
circuit. Previous work from our lab indicated this workout regimen yields an average exercise heart
rate of 126 ± 15 bpm (80% of maximal heart rate), exercise intensity of 65 ± 10% of peak oxygen uptake,
resistance exercise intensities ranging between 61% and 82% of 1RM, and expends approximately
314 ± 102 kcals per workout [37–39]. All workouts were supervised by trained fitness instructors who
monitored proper exercise technique and maintenance of adequate exercise intensity. Compliance to
the exercise program was set a priori at a minimum of 70% compliance (30/42 exercise sessions).
2.4. Diet Intervention
As consistent with several previously published studies [14,15,40–44] from our research group
over the past ten years and has encompassed over 750 research participants, participants in this
study were assigned at baseline in a block fashion according to age and body mass: (1) No dietary
modification (CTL); (2) A low-calorie, higher-protein (LCHP) diet consisting of 15% carbohydrates,
55% protein, and 30% fat); or, (3) A low-calorie, higher-carbohydrate (LCHC) diet consisting of 55%
carbohydrates, 15% protein, and 30% fat). Across the entire 14-week study protocol, the LCHP and
LCHC diets consisted of 1200 kcal/day for 1 week and 1600 kcal/day for 9 weeks. For the remaining four
weeks, participants in these groups were instructed to weigh themselves daily while ingesting a 2600
kcal/day diet (55% carbohydrates, 15% protein, 30% fat). When three pounds (~1.5 kg) were gained,
participants were instructed to follow a 1200 kcal/day until the gained weight was lost. Previous
research has demonstrated that this 14-week program promotes a 3–5 kg weight loss while maintaining
resting energy expenditure in sedentary overweight pre-menopausal women [12,13,27–31]. Of note,
participants were given diet plans and menus to follow at the start of the study. Participants also met
with a registered dietitian at each testing session to discuss diet compliance.
2.5. Supplementation Protocol
As previously observed by Wang et al. [28] assessing the bioavailability and therefore potential
differential impact on weight loss while following higher or lower carbohydrate diets throughout
an exercise program was the key rationale for using different forms of calcium. Towards this aim,
participants were assigned to ingest in a randomized and double-blinded manner dietary supplements
containing total doses of: (1) 800 mg of a maltodextrin placebo (PLA); (2) 800 mg of calcium as
carbonate (Ca); or, (3) 800 mg of calcium as a combination of citrate tetrahydrate and citrate malate,
400 IU/day of vitamin D as cholecalciferol, 300 mg of magnesium as magnesium oxide, 7.5 mg of
zinc as zinc gluconate, 2 mg of copper as hydrolyzed protein chelate and 2 mg of manganese as
manganese gluconate (Ca+D). Each participant’s total dose was evenly divided into two equal daily
doses. Participants were instructed to consume their assigned dosage 30 min before eating in the
morning and again in the evening before an evening meal for 14 weeks. Supplements were prepared
by Nutra™ Manufacturing (Greenville, SC, USA) and prepared in generic and coded bottles for double
blinded administration. Supplementation compliance was monitored by having the participants return
empty bottles of the supplement at the end of each testing phase. In addition, internal monitoring
of supplementation compliance occurred with participants completing a compliance statement in a
post-study questionnaire.
3. Procedures
3.1. Dietary Assessment
Dietary food logs (3 weekdays and 1 weekend day) were filled out by participants during the
pre-intervention (baseline), week 1 into the intervention (week 1) and one-week prior to the post-testing
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period (week 14). Logs were reviewed by a registered dietitian and subsequently analyzed for average
energy and macronutrient intake using the ESHA Food Processor v8.6 Nutritional Analysis software
(ESHA Research Inc., Salem, OR, USA).
3.2. Resting Energy Expenditure and Metabolism
Resting energy expenditure (REE) and respiratory exchange ratio (RER) were assessed using a
ParvoMedics TrueMax 2400 Metabolic Measurement System (ParvoMedics, Inc., Sandy, UT, USA).
These tests were performed with the participants lying supine on an exam table for approximately 20
min. A dilution pump controlled the flow of air to ensure a consistent percentage of carbon dioxide
(0.8–1.2%) flowing through the metabolic cart. Data were analyzed after the first 10 min of testing
during a five-minute period of time in which criterion variables (e.g., O2 uptake and CO2 expiration)
were within a 5% range. REE assessments in a previously published study from our laboratory [14]
revealed that the coefficient of variation for REE ranged from 8.2–12.0% with a mean intra-class
coefficient of 0.942.
3.3. Body Weight and Composition
Height and body mass were determined according to standard procedures using a calibrated
electronic scale (Cardinal Detecto Scale Model 8430, Webb City, MO, USA) with a precision of ±0.02 kg.
Body composition (excluding cranium) was assessed using a Hologic Discovery W (Hologic Inc.,
Waltham, MA, USA) DXA equipped with APEX Software (APEX Corporation Software, Pittsburg, PA,
USA). Test-retest reliability studies performed with this DXA machine have previously yielded mean
coefficients of variation for bone mineral content and lean mass of 0.31–0.45% with a mean intra-class
correlation of 0.985 [44].
3.4. Resting Hemodynamics and Exercise Capacity
Resting heart rate was determined by palpation of the radial artery using standard procedures [45].
Blood pressure was assessed by auscultation of the brachial artery using an aneroid sphygmomanometer
using standard clinical procedures [45]. Resting heart rate and blood pressure measurements were
taken on the participant in the supine position after resting for 5 min. Participants were attached to a
Quinton 710 ECG (Quinton Instruments, Bothell, WA, USA) and walked on a Trackmaster TMX425C
treadmill (JAS Fitness Systems, Newton, KS, USA). Expired gases were collected using a Parvo Medics
2400 TrueMax Metabolic Measurement System (ParvoMedics, Inc., Sandy, UT, USA). Participants then
performed a standard symptom-limited treadmill exercise test following the Bruce protocol to maximal
exertion. Standard test termination criteria according to the American College of Sports Medicine were
applied [45]. Calibration of gas and flow sensors was completed every morning prior to testing and
was found to be within 3% of the previous calibration point.
3.5. Muscular Strength and Endurance
A standard isotonic Olympic bench press (Nebula Fitness, Versailles, OH, USA) was used for the
isotonic bench press testing. A 1RM testing procedure was performed using standard procedures with
2-min recovery between attempts [45]. Following 1RM testing, participants performed a maximum
number of repetitions test at 80% of 1RM using the bench press exercise to determine upper body
muscular endurance. Participants were then given five minutes of rest and completed identical 1RM
and maximal repetitions to fatigue tests using a hip sled/leg press (Nebula Fitness, Versailles, OH,
USA) [45]. Test to test reliability of performing these strength tests in our lab has yielded low mean
coefficients of variation and high reliability for the bench press (CV: 1.9%, intra-class r = 0.94) and hip
sled/leg press (CV: 0.7%, intra-class r = 0.91).
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3.6. Blood Collection and Analysis
Fasted whole blood and serum samples were collected using standard phlebotomy techniques.
Whole blood samples were analyzed for complete blood counts with platelet differentials using an
Abbott Cell Dyn 3500 (Abbott Laboratories, Abbott Park, IL, USA) automated hematology analyzer.
Serum samples were analyzed for a complete metabolic panel using a calibrated Dade Behring
Dimension RXL (Siemens AG, Munich, Germany) automated clinical chemistry analyzer. Coefficient
of variation (CV) for the tests using this analyzer was similar to previously published data for these
tests (range: 1.0 to 9.6%) [46].
3.7. Statistical Analysis
A priori power calculation was set at >0.80 and was based on the observed change in fat
mass between diet groups from previous research in our lab utilizing similar diet and exercise
interventions [14,15,40,42–44,47]. This analysis revealed that a sample size of 15–20 participants per
group was sufficient to detect meaningful changes (~2 kg) in fat mass between the hypoenergetic diet
(LC) groups. All data were analyzed with IBM® SPSS® Version 25 software (IBM Corp., Armonk, NY,
USA). General linear modal (GLM) multivariate analysis was used to determine differences between
groups at baseline. Related variables were analyzed using univariate, multivariate and repeated
measures GLM. The overall multivariate Wilks’ Lambda and Greenhouse-Geisser univariate p-levels
are reported. Data were considered significant when the probability of type I error was 0.05 or less and
statistical trends toward significance were noted if the p-level ranged between 0.05 and 0.10. Partial eta
squared effect sizes (ηp 2 ) are reported when statistical trends toward significance was observed as an
indicator of effect size [48]. An eta squared around 0.02 was considered small, 0.13 medium, and 0.26
large [48]. Tukey’s least significant differences (LSD) post-hoc analyses were performed to determine
differences among groups. Mean changes from baseline as well as percent changes from baseline were
calculated and analyzed using one-way ANOVA to determine mean changes with 95% confidence
intervals (CI). Mean changes with 95% CI’s completely above or below baseline were considered
significantly different [48]. Data are presented as means ± standard deviations, mean [95% CI] change
from baseline, or mean [95% CI] percent change from baseline.
4. Results
4.1. Baseline Characteristics
Baseline participant demographics are presented in Supplemental Table S1. Multivariate GLM
analysis revealed overall Wilks’ Lambda diet (p = 0.295), supplement (p = 0.886) and diet x supplement
(p = 0.885) effects. Significant diet effects were observed among groups in absolute resting energy
expenditure expressed in kcal/day (p = 0.01) but not relative energy expenditure expressed in kcal/kg/day
(p = 0.14). No significant differences were observed among supplemented groups.
4.2. Energy and Macronutrient Intake
Self-reported energy and macronutrient intakes are presented in Supplemental Table S2. Overall
GLM multivariate analysis revealed Wilks’ Lambda time (p < 0.001), time × diet (p < 0.001), time x
supplement (p = 0.130), and time x diet x supplement (p = 0.410) effects. Univariate analysis revealed
that energy intake was significantly reduced by 517 (95% CI: 354,681) kcals/day during the 10-week
weight loss phase of the intervention and 276 (95% CI: 107,445) kcals/day during the maintenance
period. Carbohydrate intake was significantly lower while protein intake was significantly higher
in the LCHP group. Moreover, participants in the LCHC were able to reduce fat intake to a greater
degree. Thus, the dietary intervention effectively altered energy and macronutrient intake.
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4.3. Resting Energy Expenditure and Metabolism
Supplemental Table S3 presents resting energy expenditure results. The overall GLM multivariate
analysis revealed Wilks’ Lambda time (p < 0.001), time × diet (p < 0.001), time × supplement (p = 0.854),
12, x FOR PEER REVIEW
8 of 17 absolute
and timeNutrients
x diet2020,
x supplement
(p = 0.096) effects. Univariate analysis revealed that although
REE was significantly decreased by about 80 kcal/day on average over time, no significant time effects
4.3. Resting Energy Expenditure and Metabolism
were observed in relative REE. Moreover, absolute REE decreased to a greater degree in the Ca+D
Supplemental Table S3 presents resting energy expenditure results. The overall GLM
group during the weight loss intervention but this was not significantly different when expressed
multivariate analysis revealed Wilks’ Lambda time (p < 0.001), time × diet (p < 0.001), time ×
relative supplement
to body weight.
Respiratory
ratio also
decreased
time analysis
indicative
of greater fat
(p = 0.854),
and time x exchange
diet x supplement
(p = 0.096)
effects.over
Univariate
revealed
oxidation
with
some
evidence
that
RER
decreased
from
baseline
to
a
greater
degree
in
the
LCHC
group.
that although absolute REE was significantly decreased by about 80 kcal/day on average over time,
no significant time effects were observed in relative REE. Moreover, absolute REE decreased to a

4.4. Bodygreater
Weight
and Composition
degree
in the Ca+D group during the weight loss intervention but this was not significantly
different when expressed relative to body weight. Respiratory exchange ratio also decreased over

Body
weight
andofcomposition
resultswith
are presented
in Supplemental
Table
S4.baseline
GLM to
multivariate
time
indicative
greater fat oxidation
some evidence
that RER decreased
from
a
analysis greater
of body
weight,
mass,
fat free mass, and body fat revealed Wilks’ Lambda time (p < 0.001),
degree
in thefat
LCHC
group.
time × diet (p < 0.001), time x supplement (p = 0.799), and time x diet x supplement (p = 0.507) effects.
4.4. Body Weight and Composition
Participants in the LCHC and LCHP groups experienced significantly greater fat loss (p = 0.008) and
weight
and composition
results
are time
presented
Supplemental
Table
S4. GLM multivariate
reduction inBody
percent
body
fat (p < 0.001)
over
withinno
significant
differences
observed between
analysis of body weight, fat mass, fat free mass, and body fat revealed Wilks’ Lambda time (p < 0.001),
the LCHC and LCHP groups. Meanwhile, fat free mass significantly increased in the exercise only
time × diet (p < 0.001), time x supplement (p = 0.799), and time x diet x supplement (p = 0.507) effects.
control group
while
being
maintained
in theexperienced
diet groups.
No significant
time
x supplement
Participants
in the
LCHC
and LCHP groups
significantly
greater fat
loss (p
= 0.008) and effects
were observed
ininweight
= 0.552),
fat mass
= 0.708),
free mass
(p = 0.517),
or percent
reduction
percent (p
body
fat (p < 0.001)
over(p
time
with nofat
significant
differences
observed
between body fat
the LCHC
and LCHP
Meanwhile,×fat
freetrend
mass significantly
increased
in the exercise
only(p = 0.08).
(p = 0.412)
although
a timegroups.
× supplement
diet
was observed
in percent
body fat
control
group
while
being
maintained
in
the
diet
groups.
No
significant
time
x
supplement
effects
Post-hoc analysis revealed that participants following the LCHC diet and supplementing the diet with
were observed in weight (p = 0.552), fat mass (p = 0.708), fat free mass (p = 0.517), or percent body fat
Ca+D experienced greater fat loss than those supplementing the diet with Ca (p = 0.018). A significant
(p = 0.412) although a time × supplement × diet trend was observed in percent body fat (p = 0.08). Posttime × supplement
interaction
was also following
observed
bonediet
mineral
content (p the
= 0.026).
hoc analysis revealed
that participants
theinLCHC
and supplementing
diet withHowever,
post-hocCa+D
analysis
did not
reveal
significant
differencesthe
among
groups.
experienced
greater
fat any
loss than
those supplementing
diet with
Ca (p = 0.018). A significant
time ×2 supplement
interaction
was also
observed
in bonewith
mineral
content
(p =body
0.026).composition
However, post-variables.
Figure
presents mean
changes
from
baseline
95%
CI in
hoc analysis
did not
reveal
any significant
differences
among groups.
Participants
adhering
to the
LCHC
and LCHP
diets observed
significant within-group reductions in
Figure 2 presents mean changes from baseline with 95% CI in body composition variables.
body mass, fat mass, and body fat% after 10 and 14 weeks of dieting. Changes in body composition
Participants adhering to the LCHC and LCHP diets observed significant within-group reductions in
were effectively
maintained
during
the 4-week
maintenance
in the
LCHC-Ca group
body mass,
fat mass, and
body fat%
after 10 and
14 weeks ofperiod.
dieting. Participants
Changes in body
composition
experienced
greater weight
lossduring
than the
groupperiod.
after Participants
10 and 14 weeks
of interventions
were effectively
maintained
the LCHC-PLA
4-week maintenance
in the LCHC-Ca
experienced
greater
weightbetween
loss than the
the LCHC-Ca+D
LCHC-PLA group
after
10 and 14 weeks
of at these
while nogroup
differences
were
observed
(and
LCHC-PLA)
groups
interventions
while
no differences were
observed between
the LCHC-Ca+Dgroup
(and LCHC-PLA)
respective
timepoints.
Additionally,
participants
in the LCHC-Ca+D
reported groups
greater fat-free
at these respective timepoints. Additionally, participants in the LCHC-Ca+D group reported greater
mass maintenance and a greater reduction in percent body fat after 14 weeks in comparison to changes
fat-free mass maintenance and a greater reduction in percent body fat after 14 weeks in comparison
seen in LCHC-Ca.
Noindifferences
indifferences
fat-free mass
or body
massfatwere
for the
to changes seen
LCHC-Ca. No
in fat-free
massfat
or body
massnoted
were noted
for LCHC-PLA
the
group. While
participants
in
the
LCHP
lost
body
weight
and
observed
significant
reductions
LCHC-PLA group. While participants in the LCHP lost body weight and observed significantin percent
in percent body
had on
no significant
effects on these responses.
body fat,reductions
supplementation
had fat,
no supplementation
significant effects
these responses.

Fat Free Mass
4.0

^

3.0
1.0
0.0
-1.0
-2.0

CTL

LCHC

CTL

10 Weeks

LCHC
14 Weeks

Figure 2. Cont.

Ca
LCHP

Ca+D

PLA

Ca

Ca+D

PLA

Ca+D

Ca

PLA

Ca
LCHP

Ca+D

PLA

Ca

Ca+D

PLA

Ca+D

Ca

-3.0
PLA

Δ kg

2.0

Nutrients 2020, 12, 713

Nutrients 2020, 12, x FOR PEER REVIEW

9 of 17

9 of 17

Body Fat %
1.0

^

0.0

Δ%

-1.0
-2.0
-3.0
-4.0
-5.0

CTL

LCHC

LCHP

CTL

LCHC

10 Weeks

Ca+D

Ca

PLA

Ca+D

Ca

PLA

Ca

Ca+D

PLA

Ca+D

Ca

PLA

Ca+D

Ca

PLA

Ca

Ca+D

PLA

-6.0

LCHP

14 Weeks

CTL

LCHC

LCHP

CTL

LCHC

10 Weeks

Ca+D

Ca

PLA

Ca+D

Ca

PLA

Ca

Ca+D

PLA

Ca+D

Ca

PLA

Ca+D

Ca

PLA

Ca

Ca+D

2.0
1.0
0.0
-1.0
-2.0
-3.0
-4.0
-5.0
-6.0
-7.0
PLA

Δ kg

Fat Mass

LCHP

14 Weeks

Body Mass
4.0
2.0

Δ kg

0.0
-2.0
-4.0
-6.0
-8.0

CTL

LCHC
10 Weeks

LCHP

CTL

LCHC

Ca+D

Ca

PLA

Ca+D

Ca

PLA

Ca+D

Ca

PLA

Ca+D

Ca

PLA

Ca+D

Ca

PLA

Ca+D

Ca

PLA

-10.0

LCHP

14 Weeks

Figure
2. Body
compositionchanges
changes from
(mean
[95%[95%
CI]) observed
for the placebo
Figure 2.
Body
massmass
andand
composition
frombaseline
baseline
(mean
CI]) observed
for the placebo
or ●), calcium
■),calcium
and calcium
+ Vitamin
D (Ca+DororN)
▲)groups.
groups. CTL
CTL represents
thethe control
(PLA or(PLA
•), calcium
(Ca or(Ca
),or
and
+ Vitamin
D (Ca+D
represents
(no diet,
exercise
only)
group,
LCHP represents
low calorie—high
proteindiet,
diet, exercise
(no diet,control
exercise
only)
group,
LCHP
represents
low calorie—high
protein
exercisegroup,
group, LCHC
LCHC represents low calorie—high carbohydrate, exercise group, PLA represents placebo
represents low calorie—high carbohydrate, exercise group, PLA represents placebo supplementation,
supplementation, exercise group, Ca represents calcium supplementation, exercise group, Ca+D
exerciserepresents
group, Ca
represents calcium supplementation, exercise group, Ca+D represents calcium
calcium plus Vitamin D supplementation, exercise group.† represents p < 0.05 difference
plus Vitamin
D
supplementation,
represents
p < 0.05
difference
between PLA and Ca
between PLA and Ca groups. ^ exercise
representsgroup.†
p < 0.05 difference
between
Ca and
Ca+D groups.
groups. ˆ represents p < 0.05 difference between Ca and Ca+D groups.

4.5. Resting Hemodynamics and Aerobic Capacity
Supplemental Table S5 presents resting hemodynamic and aerobic capacity data. The overall
GLM multivariate analysis revealed Wilks’ Lambda time (p < 0.001), time x diet (p < 0.001), time ×
supplement (p = 0.349), and time × diet × supplement (p = 0.862) effects. Univariate analysis revealed
no significant changes in resting heart rate over time or among diet and supplement groups. Systolic
blood pressure decreased over time (−4.5 ± 12 bpm, p = 0.001) with no time x diet (p = 0.204) differences
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observed while a trend was observed in time x supplement effects (p = 0.055). Post-hoc analysis
revealed that resting SBP was significantly lower in the Ca+D group at baseline and after 10-weeks in
comparison to the PLA group. Diastolic blood pressure also decreased from baseline in all groups
(−4.0 [−6.3, −1.7]%) with no significant time x diet (p = 0.322), time x supplement (p = 0.666), or time ×
diet × supplement (p = 0.661) effects. Relative peak oxygen uptake increased over time by 6.1 [2.9,
9.4]% with no significant differences observed among diet or supplement groups.
4.6. Muscular Strength and Endurance
Supplemental Table S6 shows upper and lower extremity muscular strength and endurance
results. Overall GLM multivariate analysis revealed Wilks’ Lambda time (p < 0.001), time × diet
(p < 0.667), time × supplement (p = 0.451), and time x diet x supplement (p = 0.557) effects. One
repetition maximum (1RM) bench press increased by 3.0 [1.8, 4.2]% while 1RM leg press increased by
13.0 [7.1,19.0]% over time. However, no significant time × diet, time × supplement, or time × diet ×
supplement effect were observed.
4.7. Blood Glucose and Lipids
Supplemental Table S7 presents blood glucose and lipid results observed. The overall GLM
multivariate analysis revealed Wilks’ Lambda time (p = 0.001), time × diet (p < 0.023), time × supplement
(p = 0.472), and time x diet x supplement (p = 0.975) effects. Univariate analysis revealed significant
time effects in total cholesterol, high-density lipoprotein, and low-density lipoprotein values with no
significant differences observed among diet or supplement groups. A significant time × diet effect was
observed in serum triglycerides with participants following the LCHC diet having lower triglyceride
values than the CTL group throughout the study and participants in the LCHP group experiencing
lower triglycerides after 10-weeks of intervention.
5. Discussion and Conclusions
The present study provides unique data examining the potential combinatorial effects of exercise
and different diets with different forms of calcium with and without vitamin D supplementation on
body composition changes in post-menopausal women that participated in an exercise program. The
primary findings reveal that the LCHC and LCHP diets promoted statistically significant decreases in
body and fat mass from weeks 0 to 14, whereas the CTL diet did not. Moreover, these findings also
indicate that calcium supplementation may operate most effectively to induce favorable changes in
body composition when combined with a hypoenergetic diet that contains a greater proportion of
carbohydrate versus protein. However, contrary to our preliminary hypothesis, there were no main
supplement effects or diet x supplement interactions with regards to changes in body composition.
These findings are discussed in greater detail below.
5.1. Primary Outcome—Weight Loss and Body Composition
Calcium and vitamin D consumption have been widely investigated with regards to their effects
on body composition. Shahar et al. [29] reported that higher calcium intake and relatively high serum
vitamin D levels were associated with a greater diet-induced weight loss over a two-year intervention.
Major et al. [21] similarly reported that low-calcium consumers experienced a significant decrease
in fat mass when supplementing with calcium and vitamin D. Similar to our findings, however,
larger-scale investigations have failed to demonstrate that calcium supplementation promotes weight
loss. For instance, Shapses et al. [31], who combined data from three 25-week placebo-controlled
trials that administered 1000 mg/day calcium supplementation and modest caloric restriction in
100 premenopausal and postmenopausal women, reported that there were no significant differences
between placebo and calcium-supplemented participants in body weight (Ca: −7.0 kg, placebo: −6.2 kg)
or fat mass changes (Ca: −5.5 kg, placebo: −4.5 kg). Wagner et al. [30] also examined the effects of a
12-week dietary intervention (500 kcal restriction) with exercise (3 d/week) and 800 mg/day of calcium
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supplementation (Ca lactate vs. Ca phosphate vs. milk) in pre-menopausal women and reported
weight loss was similar between the placebo and experimental groups (Ca lactate: 4.1 kg, Ca phosphate:
5.4 kg, milk: 4.2 kg, placebo: 5.8 kg). Thus, our data expands upon current literature to suggest that
calcium supplementation with dieting and regular exercise does not further improve changes in body
mass or body composition in post-menopausal women.
We also report that vitamin D supplementation when combined with calcium supplementation
and energy-restricted diets of varying macronutrient ratios, may exert differing influences on
body composition. Previous investigations somewhat conflict with this outcome. For example,
Zittermann et al. [49] reported that 12 months of vitamin D supplementation (3320 IU/day) and dieting
did not significantly affect weight loss in overweight subjects (vitamin D: −5.7 kg, placebo −6.4 kg).
Our data also partially align with a recent study reporting that overweight/obese women (50–75 year
of age) supplementing with 2000 IU/day of vitamin D while on a reduced-calorie diet and participating
in 225 min/week of aerobic activity lost a similar amount of body mass and percent body fat over a
12-month period compared to those that supplemented with a placebo (body mass: vitamin D −7.1 kg,
placebo −7.4 kg; percent body fat: vitamin D −4.1%, placebo −3.5%). Both of these studies, however,
did not combine vitamin D with calcium or changed the macronutrient distribution and notably, each
of these diets supplemented with higher amounts of vitamin D when compared to the present study.
Interestingly, Vimaleswaran et al. [50] performed a series of regression analyses from polymorphisms,
serum vitamin D levels and body mass index (BMI) of 42,024 participants and concluded that a higher
BMI is associated with lower serum vitamin D levels. While this association may create justification for
supplementing with vitamin D to increase serum levels, it was concluded that the potential impact of
changing BMI as a result of increasing vitamin D levels was likely to be small. Therein, while our results
are similar, we did not calculate vitamin D levels at any point in our intervention, which prevents
us from drawing conclusions surrounding any potential relationships between vitamin D levels and
changes in our measured outcomes. Our data does clearly highlight that vitamin D supplementation
does not improve body composition in females who have also incorporated dieting and/or exercise as
part of their weight loss strategy. Moreover, rather than lower vitamin D levels being a contributor to
increased body weight/body fat, becoming overweight or obese may decrease vitamin D levels, but
these are areas of inquiry in need of more research.
As mentioned previously, high calcium intakes have been associated with higher levels of
fat oxidation [20], whereas vitamin D signaling has been associated with increased thermogenic
mechanisms [22,23]. While we did not implement mechanistic measures in this study, there was not a
supplement effect for changes in REE or RER. Hence, this finding suggests that, while there are metabolic
associations with calcium and vitamin D, additional supplementation with these micronutrients at the
doses administered herein may not further enhance these metabolic processes.
It should be noted that while Ca and Ca+D exerted no significant differences in body composition
between the LCHC and LCHP groups, changes within just the LCHC group revealed that the addition
of Ca+D instigated a significant loss of fat mass while no such change was reported in the LCHC or
LCHC + Ca groups. This finding provides support that Ca+D supplementation may be more effective
for promoting fat loss while following a LCHC diet as compared to higher protein diets. These findings
agree with Major and colleagues [51] and in contrast to the findings of Holecki et al. [52] in relation to
fat mass loss. Holecki et al. [52] reported that Ca+D supplementation during a 3-month low calorie
balanced diet resulted in no additional effect on weight loss or fat loss in obese females. Additionally,
no changes in serum levels of vitamin D (as 25-(OH)-D3), parathormone, or calcium were found after
the intervention. Major and co-workers [51] reported that in overweight and obese females with
very low calcium intakes (<800 mg calcium per day), a significant decrease in fat mass was achieved
when supplementing with calcium and vitamin D (as compared to a placebo) during a weight loss
program. Clearly, methodological differences among these investigations with the present study could
account for the discrepancies in outcomes. In particular, differences in the different forms of calcium
supplementation, length of intervention, and inclusion of exercise (among others) likely contribute to
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the variability in weight loss outcomes reported. In light of this, more research should evaluate the
effects of different forms of calcium supplementation on weight loss and body composition changes
while adhering to different types of diets and exercise programs.
5.2. Secondary Outcomes—Markers of Health & Fitness
As a secondary aim, we sought to examine if calcium alone or calcium plus vitamin D
supplementation in combination with a weekly exercise program and two different restricted energy
dietary programs (higher carbohydrate and higher protein) augmented exercise adaptations. There
were spurious week 0 to 14 changes in select fitness variables within groups, although no consistent
supplement effects on the changes in strength and aerobic variables were present. Indeed, there have
been no consistent relationships established in the literature regarding calcium supplementation with
strength or aerobic fitness, nor have there been reports linking vitamin D supplementation with changes
in aerobic fitness. Hence, our findings are not surprising in this regard. Reports do exist, however,
suggesting that a low vitamin D status is linked with lower strength and muscle mass levels [53–55],
however, our study protocol lacked biochemical assessments of vitamin D and thus we were not able
to explore these relationships. Despite this association, a recent meta-analysis examining 17 clinical
trials (5072 participants) reported that vitamin D supplementation does not have a significant effect on
muscle strength, although a limited number of studies demonstrate an increase in muscle strength
in adults with vitamin D deficiency [56]. Thus, if most participants in the current study were not
vitamin D deficient, these data continue to suggest that vitamin D supplementation in general does not
augment muscle strength.
Although we report that calcium alone or calcium plus vitamin D supplementation do not affect
body composition, our data clearly demonstrate that modest caloric restriction with the employed
exercise program is more effective than exercise alone in reducing fat mass. These fat loss changes are
in agreement with our previous findings involving females with a similar exercise program and various
dietary assignments [14,15,40,43,44]. Furthermore, numerous studies have reported that hypocaloric
diets with exercise can improve body composition in younger and older females over a 12–20+ week
period, whereas resistance exercise is typically beneficial in accruing lean body mass, attenuating the
loss of fat-free mass and/or maintaining body composition [57,58].
Contrary to our preliminary hypothesis, however, the LCHC and LCHP diets promoted similar
weight and fat mass losses in the current study. In this regard, several studies have suggested
that lower-carbohydrate diets elicit more favorable changes in body composition compared to
higher-carbohydrate diets [59–62] and this may be due to chronically reducing systemic insulin levels
which, in turn, reduces adipogenic and lipogenic mechanisms [63]. However, there is also data
to suggest that lower- and higher-carbohydrate hypocaloric diets elicit similar body composition
changes. For instance, one study reported that modest calorie restriction was just as effective as a
hypocaloric low-carbohydrate diet in facilitating weight loss over a one-year period (−3.0 kg vs. −2.1 kg,
respectively; p > 0.05) [64]. A similar study reported that a hypocaloric low-carbohydrate/high-fat diet
was just as effective at eliciting weight loss in obese participants over a 24-week period compared to
a hypocaloric low-fat/high-carbohydrate diet (−11.9 kg vs. −10.1 kg, respectively; p > 0.05) [65]. A
meta-analysis examining 14 studies ranging from 3–24 months in duration determined that calorie
restriction is effective at reducing body weight regardless of whether the experimental diets were
lower- or higher-carbohydrate diets [66]. Finally, we recently examined our own data from eight trials
and determined that hypocaloric diets that were lower and higher in carbohydrate content promoted
similar improvements in weight loss and metabolic syndrome scores [47]. Therefore, while it is widely
debated as to whether or not low- versus high-carbohydrate diets promote greater weight loss, our
data suggests that the lower- and higher-carbohydrate hypocaloric diets examined herein were equally
effective at promoting weight and fat mass losses in overweight post-menopausal females that engage
in exercise training. Our findings also suggest that when following a hypocaloric diet with a higher
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proportion of carbohydrate, supplementation with calcium and vitamin D may support a greater
maintenance of fat-free mass tissue and greater losses in body fat percentage.
5.3. Limitations
Indeed our study possesses various limitations. Specifically, this study was only 14 weeks in
duration and this is a relatively short period of time to observe longer-term success of dietary and exercise
interventions. Second, while we enrolled a large number of participants, many participants did not
finish the intervention and this led to some groups containing a limited number of participants. Notably,
the reported attrition in our study protocol may have been due to the macronutrient assignments made
as part of the groups assigned to the LCHP groups as has been reported elsewhere [14] or just the
well-known attrition associated exercise and weight loss interventions. Third, we did not assess the
calcium or vitamin D status of the participants. In this regard, individuals that may have responded
well in these supplement groups could have been deficient in these micronutrients; an effect which we
are unable to establish with our current data. In this respect, while our hypotheses involving the C + D
groups centered upon the impact of added vitamin D + calcium, other minerals were also included in
this complex that could have contributed to our outcomes, however, much more research is needed in
this respect.
5.4. Conclusions
We report that calcium and vitamin D appear to have no added benefit to dietary and exercise
effects on body composition at the provided dosages of 800 mg/day of calcium and 800 mg/day
of calcium plus 400 IU/day of vitamin D. Thus, adding calcium or a combination of calcium and
vitamin D does not stimulate any greater body composition changes. Conclusions from this study
also indicated that calcium supplementation may operate most effectively to induce favorable changes
in body composition when combined with a hypoenergetic diet that contains a greater proportion of
carbohydrate versus protein. Finally, hypoenergetic diets of varying macronutrient ratios stimulate
favorable changes in body mass, fat mass, and body fat percentage. Importantly, the reader should
understand that other forms of exercise may have stimulated different changes in our measured
outcomes and that our findings are limited to following a modest circuit-style resistance-based program
in combination with different dietary regimens. Notwithstanding, this study provides valuable
data combining exercise, dietary, and nutritional supplementation approaches in post-menopausal
women and continues to suggest that shorter-term supplementation with calcium and/or vitamin
D has minimal impact on body composition changes or other exercise adaptations. The impact
of longer supplementation regimens and its potential impact on our measured outcomes requires
additional research.
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